Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,462 | 452 | 99.6% |
| Education | $37.56 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,405 | 56 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $1,261 | 64 | $0 (2023) |
| Allergan, Inc. | $858.34 | 43 | $0 (2022) |
| PFIZER INC. | $830.68 | 31 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $581.93 | 39 | $0 (2021) |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | $403.27 | 16 | $0 (2020) |
| Scilex Pharmaceuticals Inc. | $395.66 | 20 | $0 (2023) |
| Nevro Corp. | $331.55 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $267.86 | 17 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $258.59 | 14 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.75 | 1 | Curonix LLC ($105.75) |
| 2023 | $614.45 | 25 | ABBVIE INC. ($460.68) |
| 2022 | $1,403 | 50 | ABBVIE INC. ($624.19) |
| 2021 | $1,372 | 68 | AbbVie Inc. ($320.31) |
| 2020 | $891.14 | 49 | Allergan, Inc. ($214.45) |
| 2019 | $1,296 | 72 | Scilex Pharmaceuticals Inc. ($189.84) |
| 2018 | $1,762 | 87 | Collegium Pharmaceutical, Inc. ($273.18) |
| 2017 | $2,055 | 103 | PFIZER INC. ($471.34) |
All Payment Transactions
455 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $105.75 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Gastroenterology | ||||||
| 04/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/29/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Opioid Analgesic | ||||||
| 03/15/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Gastroenterology | ||||||
| 03/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/11/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.34 | General |
| Category: Opioid Analgesic | ||||||
| 02/08/2023 | Almatica Pharma LLC | LOREEV XR (Drug), GRALISE | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/23/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 99 | 353 | $35,411 | $8,389 |
| 2022 | 17 | 663 | 2,126 | $1.3M | $122,793 |
| 2021 | 18 | 845 | 2,099 | $242,287 | $139,097 |
| 2020 | 19 | 873 | 4,509 | $246,779 | $128,490 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 76 | $17,106 | $5,277 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 32 | $11,200 | $3,087 | 27.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 245 | $7,105 | $24.01 | 0.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 559 | $129,948 | $42,742 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 200 | $64,556 | $22,269 | 34.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 52 | 66 | $480,178 | $19,155 | 4.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 26 | 35 | $49,352 | $8,677 | 17.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2022 | 18 | 22 | $58,690 | $5,740 | 9.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 22 | 27 | $220,032 | $5,667 | 2.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2022 | 12 | 16 | $91,096 | $4,164 | 4.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 16 | 20 | $80,570 | $2,264 | 2.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,756 | $2,115 | 36.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 11 | 12 | $14,289 | $1,953 | 13.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 17 | 18 | $37,685 | $1,925 | 5.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 12 | 20 | $22,527 | $1,921 | 8.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 31 | 37 | $12,807 | $1,899 | 14.8% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2022 | 12 | 14 | $36,729 | $1,797 | 4.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 39 | 60 | $6,930 | $300.98 | 4.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 135 | $5,925 | $123.93 | 2.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 95 | 871 | $25,259 | $79.10 | 0.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 153 | 615 | $61,485 | $37,901 | 61.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 285 | $41,586 | $27,185 | 65.4% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 77 | 101 | $32,497 | $22,879 | 70.4% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 36 | 42 | $17,205 | $9,989 | 58.1% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 28 | 42 | $12,045 | $7,758 | 64.4% |
About Dr. Lyle Posecion, M.D
Dr. Lyle Posecion, M.D is a Physical Medicine & Rehabilitation healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235340480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lyle Posecion, M.D has received a total of $9,500 in payments from pharmaceutical and medical device companies, with $105.75 received in 2024. These payments were reported across 455 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,462).
As a Medicare-enrolled provider, Posecion has provided services to 2,480 Medicare beneficiaries, totaling 9,087 services with total Medicare billing of $398,768. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location White Plains, NY
- Active Since 05/26/2007
- Last Updated 02/06/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1235340480
Products in Payments
- BOTOX (Biological) $1,077
- XTAMPZA (Drug) $886.82
- Horizant (Drug) $581.93
- UBRELVY (Drug) $575.86
- LYRICA (Drug) $565.57
- QULIPTA (Drug) $411.53
- RELISTOR ORAL (Drug) $349.19
- Omnia (Device) $304.04
- Proclaim Family of SCS IPGs (Device) $234.80
- Xtampza ER (Drug) $213.64
- BUNAVAIL 2.1 mg 30-count box (Drug) $211.45
- ZTLido (Drug) $205.82
- BELBUCA (Drug) $191.82
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $189.84
- LORZONE (Drug) $182.96
- EMBEDA (Drug) $171.94
- SPRIX (Drug) $153.61
- Movantik (Drug) $152.76
- NURTEC ODT (Drug) $128.01
- ZOHYDRO ER (Drug) $123.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in White Plains
Dr. Bradley Cash, Md,Pmr, MD,PMR
Physical Medicine & Rehabilitation — Payments: $49,138
Lata Bhansali, M. D, M. D
Physical Medicine & Rehabilitation — Payments: $485.55
Dr. Andrew Abdou, Do, DO
Physical Medicine & Rehabilitation — Payments: $456.15
Moo-Yeon Oh-Park, Md, MD
Physical Medicine & Rehabilitation — Payments: $421.97
Dr. Stephen Andrus, Md, MD
Physical Medicine & Rehabilitation — Payments: $288.67
Dr. Eric Roberts, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $275.84